Back

Predictors of coronary artery disease in patients with acute heart failure: do they all benefit from invasive coronary angiography?

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - diagnostic methods Diagnostic Methods HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Mauro Moreira

Hospital Centre do Tamega e Sousa, Penafiel (Portugal)

8 More presentations in this session

Presentation thumbnail
Non-invasive hemodynamic measurement using whole-body impedance cardiography in patients hospitalized due to congestive heart failure: an effective alternative to invasive right heart catheterization?
Doctor M. Haj Abdo (Bad Neustadt a. d. Saale, DE)
Abstract Slides
Presentation thumbnail
Impact of pulmonary valve regurgitation severity on biomarkers, functional capacity, and clinical findings in heart failure patients
Associate Professor B. MURAT (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
Hyperinflation and contribution to volume overload and functional capacity in heart failure
Doctor M. Lorenzo Hernandez (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Prediction of LVEF improvement with cardiopulmonary exercise testing in ambulatory patients with severely reduced LVEF
Mr J. Schenk (Jena, DE)
Abstract Slides Video
Presentation thumbnail
TARTAN-HF: trial design and methods
Doctor D. Taylor-Sweet (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - diagnostic methods

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
When is coronary artery disease the real culprit behind unstable angina?
thumbnail
Congress Presentation
Echocardiographic predictors for chronic coronary artery disease in patients with ST-T alterations
thumbnail
Congress Presentation
Refining coronary artery disease detection: integrating left ventricular longitudinal strain and high-sensitivity C-reactive protein for risk stratification

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources